Lv4
472 积分 2023-09-19 加入
Nivolumab and ipilimumab combination treatment in patients with advanced intrahepatic cholangiocarcinoma and gallbladder cancer: Results from the phase II MoST-CIRCUIT trial
11天前
已完结
FAP-Targeted Theranostics in Advanced Sarcoma: A Pilot Study of ⁶⁸Ga-FAPI-46 Imaging and ¹⁷⁷Lu-FAPI-2286 Therapy
13天前
已完结
Excellent Response to 177Lu-DOTA-IBA Therapy of Patients With Multiple Skeletal Metastases
27天前
已关闭
Chelator-guided radiosynthesis, preclinical evaluation, and clinical study of [68 Ga]Ga-TRAP-(FAPI)3 for positron emission tomography imaging of tumors
1个月前
已关闭
Navigating the Evolving Landscape of EGFR-Mutated NSCLC
1个月前
已完结
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC - mechanisms and evolving treatment approaches
1个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
1个月前
已完结
The evolution of the treatment of non–small cell lung cancer: A shift in surgical paradigm to a more individualized approach
1个月前
已完结
Efficacy and safety of MYL-1501D vs insulin glargine in patients with type 1 diabetes after 52 weeks: Results of the INSTRIDE 1 phase III study
1个月前
已完结
Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn's disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trial
2个月前
已完结
皖公网安备34019202002308
